drugset / Trial / NCT00840242

Smoking Reduction or Cessation With Nicotine Replacement Therapy

NCT00840242

Phase 3 Completed 314 enrolled McNeil AB
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to test the success rate of smoking reduction or cessation with different nicotine products.

Timeline

Start
1999-02
Primary completion
2000-05
Completion
2000-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown

Indications

No indication recorded.